News

October 14, 2019October 14, 2019

Ankylosing Spondylitis Psoriasis, Axial Psoriatic Arthritis Unrelated, Study Says

News

Psoriasis in ankylosing spondylitis (AS) patients is not related to axial psoriatic arthritis (PsA), a type of psoriasis causing lower back inflammation and pain similar to AS, a new ... Read more

October 10, 2019October 10, 2019

Anti-TNF Therapy Slows Down AS Progression and Bone Loss, Study Says

News

Anti-TNF therapies can halt disease progression and bone loss, and are associated with clinical improvement in people with ankylosing spondylitis after one year of treatment, a study shows. The ... Read more

October 7, 2019October 7, 2019

Cosentyx Effectively Lowers Disease Activity in nr-axSpA Patients Treated for 1 Year, Phase 3 Trial Reports

News

Treatment with Novartis’ Cosentyx (secukinumab) significantly reduced disease activity compared to placebo in patients with non-radiographic axial spondyloarthritis (nr-axSpA), according to new data from the Phase 3 PREVENT trial. The ... Read more

October 3, 2019October 3, 2019

AS Patients at Greater Risk of Other Inflammatory Diseases, Taiwanese Study Reports

News

People with ankylosing spondylitis (AS) are at a greater risk of developing certain inflammatory diseases — specifically, Behcet’s disease, Buerger’s disease, acute anterior uveitis, sarcoidosis, and psoriasis, according to a Taiwanese ... Read more

September 30, 2019September 30, 2019

Heat Therapy Called Moxibustion May Help People with Ankylosing Spondylitis, Short-term Study Finds

News

Moxibustion, a form of heat therapy widely used in East Asia, given in combination with conventional treatments may be of benefit to people with ankylosing spondylitis, at least in ... Read more

September 26, 2019

NORD 2019 Rare Disease Summit Set for Oct. 21-22 in Washington, DC

News

Next month’s annual conference of the National Organization for Rare Disorders (NORD) in Washington, D.C., couldn’t come at a better time, says Marshall Summar, MD, chairman of NORD’s board ... Read more

September 26, 2019September 26, 2019

Depression More Common in People with Ankylosing Spondylitis, Analysis Shows

News

Depression is more common among people with ankylosing spondylitis (AS) than in the general population, with about a third of patients experiencing depressive symptoms, a meta-analysis reveals. The study, ... Read more

September 23, 2019September 23, 2019

Cosentyx Shows Promise in Managing nr-axSpA Disease Activity, Phase 3 Trial Shows

News

Treatment with Novartis’ Cosentyx (secukinumab) led to a significant reduction in disease activity compared to placebo in patients with non-radiographic axial spondyloarthritis (nr-axSpA), according to results from the ongoing Phase 3 PREVENT trial. ... Read more

September 19, 2019September 19, 2019

Diffusion-weighted Imaging Useful to Identify Axial Spondyloarthritis

News

A specific type of MRI called diffusion-weighted imaging is sensitive enough to identify patients with early signs of axial spondyloarthritis, a study has f0und. Results of the study, “Diffusion-weighted ... Read more

September 16, 2019September 16, 2019

Biosimilar to Humira, IBI303, Shows Comparable Efficacy and Safety in Phase 3 Trial in China

News

Treating ankylosing spondylitis (AS) patients with Humira (adalimumab) or a potential biosimilar called IBI303 had comparable effects in reducing disease activity and improving quality of life, and showed a similar safety ... Read more

Pin It on Pinterest